Find a Takeda Representative

We're here to help. Your local Takeda representative is happy to help answer questions about Takeda products, programs, and services.

All fields are required unless marked optional.

CONTACT INFORMATION

First Name:

Last Name:

ZIP Code:

Representative Communication Preference (select one or more):

Phone

Mobile Phone Number:

Email:

Tell us more about your specialty:

By checking this box and clicking submit, you certify that you are a US healthcare professional and you are opting to receive information about bleeding disorders plus, product information, educational information, patient support resources, and other information from Takeda. You may unsubscribe from these communications at any time by clicking on the unsubscribe link in the email communication.

By providing your personal and/or medical data and clicking on the submit button, you authorize Takeda to use this information to provide you with information, resources, services, and communication via email, direct mail, text, or otherwise. Additionally, your information may be used for market research purposes. Takeda respects your personal information. All personal and/or medical information you have provided will be kept confidential and will not be used or distributed to anyone for any purpose other than what is explained in our Privacy Notice. We encourage you to read our Privacy Notice by clicking on this link: Review Takeda Privacy Notice. This consent will be in effect until such times as you opt out of the program.

See LessMore

Cookie Use Notification

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies
as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies.

Find out more

Indications for FEIBA

FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for:

Control and prevention of bleeding episodes

Detailed Important Risk Information

WARNING: EMBOLIC and THROMBOTIC EVENTS

Thromboembolic events have been reported during post-marketing surveillance following infusion of FEIBA,

Indications for FEIBA

FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in
hemophilia A and B patients with inhibitors for:

Control and prevention of bleeding episodes
Perioperative management
Routine prophylaxis to prevent or reduce the frequency of bleeding episodes

FEIBA is not indicated for the treatment of bleeding episodes resulting from...

Detailed Important Risk Information

WARNING: EMBOLIC and THROMBOTIC EVENTS

Thromboembolic events have been reported during post-marketing surveillance following infusion of FEIBA, particularly following the administration of high doses (above 200 units per kg per day) and/or in patients with thrombotic risk factors.
Monitor patients receiving FEIBA for signs and symptoms of thromboembolic events.

;

Find a Takeda Representative

CONTACT INFORMATION

Indications for FEIBA

Detailed Important Risk Information

Indications for FEIBA

Detailed Important Risk Information

You are now navigating away from feiba.com

FOR U.S. HEALTHCARE PROFESSIONALS ONLY